A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...
Gadget Review on MSN
Gene editing breakthrough could end your daily cholesterol pills – here's what it means for you
CRISPR therapy STX-1150 could replace daily cholesterol pills with a single dose, reducing LDL by 50% for 18+ months using ...
Morning Overview on MSN
Gene editing breakthrough could kill off daily cholesterol pills
For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...
One of the main goals in the prevention of cardiovascular disorders is to maintain low-density lipoprotein cholesterol (LDL-C) at consistently low levels to ensure long-term cardiovascular protection.
The last time I wrote about Verve Therapeutics (VERV), it was in a Seeking Alpha article entitled "Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts." With ...
Metastasis is responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem from a commonly inherited variant of the PCSK9 gene. Metastasis is responsible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results